Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1553759
PUBLISHER: GlobalData | PRODUCT CODE: 1553759
Spain Digital Health Market Outlook to 2033 - Electronic Health Records, Regulatory Approved Apps and Telehealth
PUBLISHED:
PAGES: 111 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's "Spain Digital Health Market Outlook to 2033" is a comprehensive databook report, covering key market data on the Spain Digital Health market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Electronic Health Records, Regulatory Approved Apps and Telehealth
The Spain Digital Health Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2023 company share and distribution share data for Digital Health Market.
- Global corporate-level profiles of key companies operating within the Spain Digital Health Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
Spain Digital Health is segmented as follows -
- Electronic Health Records
- Regulatory Approved Apps
- Telehealth
Reasons to Buy
Spain Digital Health Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME0105MDB
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
- 2.2 Digital Health Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
3 Digital Health Market, Spain
- 3.1 Digital Health Market, Spain, Revenue ($m), 2018-2033
- 3.2 Digital Health Market, Spain, Revenue Mix ($m), 2023
- 3.3 Digital Health Market, Spain, Category Contribution by Revenue ($m), 2023
- 3.4 Digital Health Market, Spain, Revenue ($m), 2018-2033
- 3.5 Digital Health Market, Spain, Volume (Units), 2018-2033
- 3.6 Digital Health Market, Spain, Volume (Units), 2018-2033
- 3.7 Digital Health Market, Spain, Company Share by Revenue ($m), 2023
4 Electronic Health Records Market, Spain
- 4.1 Electronic Health Records Market, Spain, Revenue Mix ($m), 2023
- 4.2 Electronic Health Records Market, Spain, Segment Contribution (%), 2023
- 4.3 Electronic Health Records Market, Spain, Revenue ($m), 2018-2033
- 4.4 Electronic Health Records Market, Spain, Volume (Units), 2018-2033
- 4.5 Electronic Health Records Market, Spain, Average Price ($) , 2018-2033
- 4.6 Electronic Health Records Market, Spain, Distribution Share by Revenue ($m), 2023
- 4.7 Electronic Health Records Market, Spain, Company Share by Revenue ($m), 2023
5 Regulatory Approved Apps Market, Spain
- 5.1 Regulatory Approved Apps Market, Spain, Revenue Mix ($m), 2023
- 5.2 Regulatory Approved Apps Market, Spain, Segment Contribution (%), 2023
- 5.3 Regulatory Approved Apps Market, Spain, Revenue ($m), 2018-2033
- 5.3.1 Clinical-Focused Apps Market, Spain, Revenue ($m), by Segment, 2018-2033
- 5.3.2 Indication Specific Mobile Apps Market, Spain, Revenue ($m), by Segment, 2018-2033
- 5.4 Regulatory Approved Apps Market, Spain, Volume (Units), 2018-2033
- 5.4.1 Clinical-Focused Apps Market, Spain, Volume (Units), by Segment, 2018-2033
- 5.4.2 Indication Specific Mobile Apps Market, Spain, Volume (Units), by Segment, 2018-2033
- 5.5 Regulatory Approved Apps Market, Spain, Average Price ($), 2018-2033
- 5.6 Regulatory Approved Apps Market, Spain, Distribution Share by Revenue ($m), 2023
- 5.7 Regulatory Approved Apps Market, Spain, Company Share by Revenue ($m), 2023
6 Telehealth Market, Spain
- 6.1 Telehealth Market, Spain, Revenue Mix ($m), 2023
- 6.2 Telehealth Market, Spain, Segment Contribution (%), 2023
- 6.3 Telehealth Market, Spain, Revenue ($m), 2018-2033
- 6.4 Telehealth Market, Spain, Volume (Units), 2018-2033
- 6.5 Telehealth Market, Spain, Average Price ($) , 2018-2033
- 6.6 Telehealth Market, Spain, Distribution Share by Revenue ($m), 2023
- 6.7 Telehealth Market, Spain, Company Share by Revenue ($m), 2023
7 Overview of Key Companies in Spain, Digital Health Market
- 7.1 Teladoc Health Inc
- 7.1.1 Company Overview
- 7.2 Cerner Corp
- 7.2.1 Company Overview
- 7.3 Constellation Software Inc
- 7.3.1 Company Overview
- 7.4 Concentrix Corp
- 7.4.1 Company Overview
- 7.5 CompuGroup Medical SE & Co KGaA
- 7.5.1 Company Overview
8 Digital Health Market Pipeline Products
9 Financial Deals Landscape
- 9.1 Acquisition
- 9.1.1 Syntegon to Acquire Azbil Telstar
- 9.1.2 DHG Acquires MediCauce
- 9.1.3 JPMorgan Acquires 10.6% Stake in Indra Sistemas for USD294.3 Million
- 9.1.4 2518542 Alberta Acquires Khiron Europe from Khiron Life Sciences for USD2.18 Million
- 9.2 Debt Offerings
- 9.2.1 Grifols Raises USD1.06 Billion in Private Placement of 7.5% Senior Secured Notes Due 2030
- 9.3 Partnerships
- 9.3.1 Indra to Enter into Partnership Agreement with Parsons
- 9.3.2 Theranica Enters into Agreement with Dr. Reddy's Laboratories
- 9.4 Venture Financing
- 9.4.1 Home Diagnostics (Ailin) Raises USD1.61 Million in Venture Financing
- 9.4.2 Avamed Synergy Raises USD0.87 Million in Venture Financing
- 9.4.3 Idoven 1903 Raises Fund through Venture Financing
- 9.4.4 Zerintia HealthTech Raises USD1.08 Million Series A Financing
10 Recent Developments
- 10.1 Corporate Communications
- 10.1.1 Mar 26, 2024: Som Biotech Announces the Election of Silvia Panigone as Executive Chair
- 10.1.2 Feb 01, 2024: Grifols Names New Senior Executives
- 10.1.3 Dec 19, 2023: Victor Grifols Roura Announces Retirement from Grifols Board of Directors; Albert Grifols ComaCros assumes the vacated seat
- 10.1.4 Dec 18, 2023: IBEC to Develop Organs-On-A-Chip in Three Pathfinder Projects
- 10.1.5 Sep 04, 2023: Grifols names Dr. Jorg Schuttrumpf Chief Scientific Innovation Officer
- 10.2 Financial Announcements
- 10.2.1 Feb 29, 2024: Grifols Closes a Record Year and Accelerates Profitable Growth for 2024
- 10.2.2 Feb 06, 2024: INSERTING and REPLACING GE HealthCare Reports Fourth Quarter and Full Year 2023 Financial Results
- 10.2.3 Jan 25, 2024: Cegedim Announces Q4 2023 Revenues
- 10.2.4 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results
- 10.2.5 Oct 26, 2023: Cegedim Posts Q3 Revenue
- 10.2.6 Oct 09, 2023: Biokit Receives 510(k) Clearance for ARCHITECT HSV-1 IgG Assay
- 10.2.7 Jul 20, 2023: Avail Medsystems Announces Participation throughout the Society of Robotic Surgery (SRS) Annual Meeting
- 10.3 Government and Public Interest
- 10.3.1 Feb 14, 2024: GE HealthCare Management to Present at Upcoming Investor Conferences
- 10.4 Other Significant Developments
- 10.4.1 Apr 10, 2024: Cedars-Sinai Launches Virtual Healthcare for Children and Spanish Speakers
- 10.4.2 Jan 17, 2024: Bioadaptives Announces Signing of a New Distributor's Agreement for AI Body Composition Measuring App and New Weight Management System
- 10.4.3 Jan 02, 2024: ValGenesis VLMS to Drive Digital Transformation for Leading Spanish Pharmaceutical Company
- 10.4.4 Sep 06, 2023: The United Laboratories International Holdings : Updated Information of the Group's Products - Meropenem for Injection
- 10.5 Product News
- 10.5.1 May 28, 2024: Painchek Receives European Patent For Pain Assessment Technology
- 10.5.2 Oct 20, 2023: GC Genome to Present the Latest Lung Cancer Diagnostic Tool at ESMO 2023
- 10.5.3 Oct 16, 2023: Median Technologies' Global iCRO Team to participate in the 2023 ESMO Congress, Oct 20 - 24, 2023, Madrid, Spain
- 10.6 Strategy And Business Planning
- 10.6.1 Jan 31, 2024: Almirall and Microsoft announce partnership for digital transformation to enable the development of novel treatments for skin diseases
- 10.6.2 Oct 19, 2023: Massive Bio and ONCOassist Announce Strategic Partnership at ESMO 2023
- 10.6.3 Aug 01, 2023: Cadrenal Therapeutics Expands Focus for Tecarfarin to Patients with Implanted Medical Devices for Heart Diseases
- 10.6.4 Aug 01, 2023: Grifols Accelerates Healthcare Innovation With Google Cloud's AI and Analytics
- 10.6.5 Jul 24, 2023: New Collaboration With Blue Zone Studio to Create an OCD Monitoring Application
- 10.6.6 Jul 11, 2023: The Community of Madrid Selects Essence SmartCare to Provide Advanced Remote Care Technologies for Senior and Disabled Citizens
- 10.6.7 Jun 29, 2023: Cegedim Announces a Forward-Looking Partnership With Gustave Roussy to Mark the 30th Anniversary of Its European Real-World Database, Thin
- 10.6.8 Jun 22, 2023: Ibec's Bioimaging Facility Opens With a New Nuclear Magnetic Resonance Equipment
11 Appendix
- 11.1 Research Methodology
- 11.1.1 Coverage
- 11.1.2 Secondary Research
- 11.1.3 Primary Research
- 11.1.4 Market Modeling and Forecasting
- 11.1.5 Company Share Analysis
- 11.1.6 Distribution Share Analysis
- 11.1.7 Benchmarking
- 11.2 GlobalData Consulting
- 11.3 Contact Us
- 11.4 Disclaimer
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.